(Q30478981)

English

Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study (English)

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

Kristjana Einarsdóttir

object named as

Kristjana Einarsdóttir

1

0 references

object named as

Juni Palmgren

5

0 references

10

object named as

Per Hall

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Keith Humphreys

3

object named as

Keith Humphreys

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

11

object named as

Jianjun Liu

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

12

object named as

Sara Wedrén

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

author name string

Lena U Rosenberg

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Carine Bonnard

4

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Yuqing Li

6

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Yi Li

7

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Kee S Chia

8

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Edison T Liu

9

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

8

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

6

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

R67

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Genes, environment and the value of prospective cohort studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

ATM haplotypes and breast cancer risk in Jewish high-risk women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Cancer risks and mortality in heterozygous ATM mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The genetic epidemiology of breast cancer genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The structure of haplotype blocks in the human genome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Dominant Negative ATM Mutations in Breast Cancer Families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Score tests for association between traits and haplotypes when linkage phase is ambiguous

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Linkage disequilibrium in humans: models and data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Brassica vegetables and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Untangling the ErbB signalling network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Breast cancer risk and lifetime leisure-time and occupational physical activity (Sweden).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Requirement for neuregulin receptor erbB2 in neural and cardiac development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

20 June 2018

Genetic background is an important determinant of metastatic potential.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Association of family history and other risk factors with breast cancer risk (Sweden).

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Sample size requirements for matched case-control studies of gene-environment interaction

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

An utter refutation of the "fundamental theorem of the HapMap".

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

ATM missense mutations are frequent in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

An allelic variant at the ATM locus is implicated in breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

ATM heterozygosity and cancer risk

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

26 November 2018

UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

26 November 2018

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1797028

26 November 2018

Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1

1 reference

https://api.crossref.org/works/10.1186%2FBCR1623

21 January 2018

Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obtaining unbiased estimates of tagging SNP performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of germ-line genetic variation on breast cancer survival in a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of ataxia-telangiectasia heterozygotes in familial breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17132159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR1623

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/bcr1623

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30478981&oldid=2175369973"